INTERNATIONAL PATENT: CREATE MEDICINES, INC. FILES APPLICATION FOR "NUCLEIC ACIDS ENCODING ENGINEERED CHIMERIC FUSION PROTEINS"

GENEVA, March 25 -- CREATE MEDICINES, INC. (300 Technology Square, Suite 203Cambridge, Massachusetts 02139) filed a patent application (PCT/US2025/045800) for "NUCLEIC ACIDS ENCODING ENGINEERED CHIMERIC FUSION PROTEINS" on Sep 10, 2025. With publication no. WO/2026/060032, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAURER, Matthew Anthony (c/o CREATE MEDICINES, INC.300 Technology SquareSuite 203Cambridge, Massachusetts 02139), GETTS, Daniel (c/o CREATE MEDICINES, INC.300 Technology SquareSuite 203Cambridge, Massachus...